An interventional study of Pulsed Radiofrequency Ablation in Faceto-genic Neck Pain, Shoulder Pain Chronic and Faceto-genic Headache, sponsored by Allevio Pain Management Clinic. Status unknown at 2 sites in Canada. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2022-06-23.
Sponsored by Allevio Pain Management Clinic · Not applicable, Interventional, and Treatment
Different studies have revealed different success rates and patient satisfaction after cervical facet C-RF. In a study on 32 patients, with 15 months follow up, 25% had complete pain relief (8). Another study had shown mean pain relief of 12.5 months and 11.5 months following a repeat procedure, with an effectiveness of 95% in 47 patients (8). In one study a success rate of 88% after first RF, and 86% following a repeat RF in 49 patients with facet mediated cervicogenic headache. They regarded the absence of anesthesia in the distribution of the 3rd occipital nerve, a technical failure (9). In a study from New Zealand, demonstrated cervical facet RF as the sole treatment modality, produced 61% -74% complete pain relief with a median duration of 15-17 months in patients who had responded to facet joints diagnostic block (10).
One more study in 2012 has demonstrated high voltage P-RF had a higher short-term effect compare to usual voltage, but results are still lower than C-RF (11). A double blind randomized prospective study has illustrated P-RF did not show any success rate in 6 months pain control, whereas C-RF had 95% pain control for trigeminal neuralgia (12).
Cohen in a recent study has compared P-RF with steroid injection for occipital neuralgia or migraine with occipital nerve tenderness (13). Six weeks pain relief was 61% in P-RF group, and 36% in steroid injection group, with a positive outcome of 34%, and 26% respectively (13). One study on 2010 had reached to 52.6%, 6 months pain improvement on occipital neuralgia (14).
Patients fulfilling eligibility criteria will be randomly allocated to PRF or CRF in a 1:1 ratio. The statistician will use RedCap software to generate random numbers. Patients will be registered to Redcap software and will be concealed from both patients and health care staff. The study coordinator will enter patients' consent and study eligibility information to the Redcap. Once eligible, the Redcap will assign the patient to one of the study group. Patients will be blinded in the proposed study. The assessor is the person who will assess treatment success at the end of the study based on data from completed questionnaires. Questionnaires will be completed every three months by patients through RedCap System. A therapist is the person who will perform the procedure (pain specialist physician). The therapist will not be blinded, because of the nature of intervention.
Patient recruitment is estimated to be completed within 15-24 months. If the required sample size (calculated below) is recruited prior to this time, patient recruitment will be curtailed.
During the first visit the investigator will perform eligibility for neck RF and patient will be received information about the study.
Patients will be book for two MBB 4-6 weeks apart. If the patient was eligible after the second MBB, Patient will be asked to sign Informed consent before screening. Screening and recruitment, and randomization, and administer questionnaires will be performed by research co-ordinator. Study informed consent form (ICF) can be signed on the RF procedure day. If additional visits will be required to finalize the procedures related to the first visit they will be scheduled accordingly. After randomization the qualified participants will be scheduled for their RF.
For the female subjects between the age of 18-50 a pregnancy test will be asked to obtain on screening visit in order to reduce the risk of pregnancy and potential harm to fetus, unless you had previous tubal ligation, or hysterectomy. Post menopause patients are excluded.
Participants will be asked to complete the follow-up questionnaires at 1, 3, 6, 9, and 12 months.
LANSS questionnaire will be asked to be completed 6 weeks after RF. If the score was 12 or higher, patient will be asked to complete them every 4 weeks after till the score reduce to less than 12. LANSS will be sent to the subjects through RedCap software.
On their last study visit, participants will have an exit interview, in addition to completing study measures.
2,999 studies on the registry are indexed under Chronic Pain; 706 are open to participants now.
This study's planned enrollment of 88 is above the median of 60 across 2,209 interventional studies indexed under Chronic Pain.
Browse Chronic Pain studies →Allevio Pain Management Clinic is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age 18-90;
Pain duration > 3 months
Cervical, Shoulder pain or cevicogenic Headache per Pain Diagram;
Two single blinded facet medial branch blocks (MBB) performed 30 days prior to the facet RF;
Subjects show 50% and more pain relief after each MBB (using VAS for this assessment);
Unsuccessful or poorly tolerated previous treatments including: pain control medications, chiropractic, osteopathy, massage therapy, physiotherapy, acupuncture, aqua therapy, Botox injection, and trigger point injection;
Exclusion Criteria:
Non-English speakers;
Refusal to sign informed consent;
Less than 50% pain relief after MBB (using VAS);
Variation in the dose of concomitant pain control medication less than 4 weeks before the procedure;
Allergy to medication or radiology contrast;
Patients with coagulation issues, those currently using anticoagulants and didn't stop them based on Allevio clinic's policy for anticoagulants;
Pregnant patients;
Any pain interventions including previous RF, MBB, infusions 90 days prior to the first MBB for the same area (Except failed Botox injection, and trigger point injection);
Radiofrequency ablation of sensory nerves at minimum 3 levels of cervical spine with Maximum allowable temperature 50° rotation: 90.; Pulse rate: 3 Hz; pulse duration: 50 ms; 3 minutes
Procedure: Pulsed Radiofrequency Ablation
Radiofrequency ablation of sensory nerves at minimum 3 levels of cervical spine, burn will be made at 80° for 60 seconds.
Procedure: Pulsed Radiofrequency Ablation
Radiofrequency ablation, also called rhizotomy, is a nonsurgical, minimally invasive procedure that uses heat to reduce or stop the transmission of pain. Radiofrequency waves ablate, or "burn," the nerve that is causing the pain, essentially eliminating the transmission of pain signals to the brain.
Also known as: Continuous Radiofrequency Ablation
Quality of life measurement: Visual Analogue Scale
Changes in Visual Analogue Scale (VAS), between minimum of zero and maximum of ten
Time frame: Beginning of the study , and every 3 months up to 12 months
Quality of life measurement: Neck Disability Index
Changes in the Neck Disability Index - AAOS(NDI\_AAOS)
Time frame: Beginning of the study , and every 3 months up to 12 months
Quality of life measurement: Short Form Brief Pain Inventory
Changes in the Short Form Brief Pain Inventory (SF-BPI), between minimum of zero and maximum of ten
Time frame: Beginning of the study , and every 3 months up to 12 months
At least 30% Changes in Pain Score
Proportion of subjects who achieve at least a 30% decrease in the pain score measured by Visual analogue Scale , between minimum of zero and maximum of ten
Time frame: Beginning of the study , and every 3 months up to 12 months
At least 30% Changes in Pain Score
Proportion of subjects who achieve at least a 30% decrease in the pain score measured by Short Form Brief Pain Inventory , between minimum of zero and maximum of ten
Time frame: Beginning of the study , and every 3 months up to 12 months
At least 30% Changes in Pain Score
Proportion of subjects who achieve at least a 30% decrease in the pain score measured by The Neck Disability Index , between minimum of zero and maximum of ten
Time frame: Beginning of the study , and every 3 months up to 12 months
At least 50% Changes in Pain Score
Proportion of subjects who achieve at least a 50% decrease in the pain score measured by The Neck Disability Index
Time frame: Beginning of the study , and every 3 months up to 12 months
At least 50% Changes in Pain Score
Proportion of subjects who achieve at least a 50% decrease in the pain score measured by Short Form Brief Pain Inventory , between minimum of zero and maximum of ten
Time frame: Beginning of the study , and every 3 months up to 12 months
At least 50% Changes in Pain Score
Proportion of subjects who achieve at least a 50% decrease in the pain score measured by Visual analogue Scale , between minimum of zero and maximum of ten
Time frame: Beginning of the study , and every 3 months up to 12 months
Changes in Changes in Global Improvement and Satisfaction
Changes in Global Improvement and Satisfaction score measured by PGIC
Time frame: Beginning of the study , and every 3 months up to 12 months
Changes in The Neck Disability Index
Changes in The Neck Disability Index - AAOS(NDI\_AAOS)
Time frame: Beginning of the study , and every 3 months up to 12 months
Changes in General Anxiety Disorder Questionnaire
Changes in General Anxiety Disorder Questionnaire (GAD)
Time frame: Beginning of the study , and every 3 months up to 12 months
Changes in Beck's Depression Inventory
Changes in Beck's Depression Inventory (BDI)
Time frame: Beginning of the study , and every 3 months up to 12 months
Changes in Changes in Patients self-reported perceived duration of effect
Changes in Patients self-reported perceived duration of effect (PSPDE)
Time frame: Beginning of the study , and every 3 months up to 12 months
Adverse events
Safety, assessed by the number, severity and duration of adverse reactions. It will be collected as self-rated health-related complaints by the subject and then confirmed medically. The causality will be assigned by the investigator
Time frame: Beginning of the study , and every 3 months up to 12 months
Pain Medications
Changes in pain medication use, if it is narcotic, measured by Morphine Equivalent Dose
Time frame: Beginning of the study , and every 3 months up to 12 months
Changes in Leeds assessment of neuropathic symptoms and signs
Changes in the Leeds assessment of neuropathic symptoms and signs (LANSS), between minimum of zero and maximum of twenty four
Time frame: 6 weeks after RF and if the score was 12 or higher repeat monthly up to 12 weeks
Plan to share: No — Results will be published
Started Feb 2020 (actual). Primary completion is estimated for Dec 2025, 70 months after the start.
Of 1,209 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 70 months is above that.
Counting every sponsor, half of 1,296 studies reached it within 21 months; a quarter within 9 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Allevio Pain Management Clinic